Home 5 Lab Compliance Advisor 5 CLIA-lca 5 AMP Offers Proposal for Regulation of Laboratory Developed Tests

AMP Offers Proposal for Regulation of Laboratory Developed Tests

by | Aug 31, 2015

Last month in Compliance Perspectives, we highlighted the current status of the Food and Drug Administration’s proposed regulation of laboratory-developed tests (LDTs). While the FDA’s proposed framework remains to be finalized, other stakeholders are proposing alternative oversight models. This month, the Association for Molecular Pathology issued a proposal for modernizing CLIA regulations. The proposal reiterates […]

Last month in Compliance Perspectives, we highlighted the current status of the Food and Drug Administration’s proposed regulation of laboratory-developed tests (LDTs). While the FDA’s proposed framework remains to be finalized, other stakeholders are proposing alternative oversight models. This month, the Association for Molecular Pathology issued a proposal for modernizing CLIA regulations. The proposal reiterates […]

This content is Exclusive to Lab Compliance Advisor Subscribers

Subscribe or Log in for Exclusive Access.